Cannabis yɩɩlem la Cannabinoid Sayɛnsɩ yaa Region Centre-Est tɩ: Bɩɩɩb Global n yi OilWell Cannabis

Yaa bõn-naasã yaoolem t’a kareng sẽn yi tɩrga la tɩrg yɩɩlem sayɛnsɩ. Tõnd yaa OilWell Cannabis, Houston cannabis yʋʋr sẽn be Amerika, la bɩɩɩb zĩig sẽn kõ sɩd-kõt tɩ tʋm cannabinoid tuumsã, yɩɩgla, la kosg sẽn yaa zãmba pʋgẽ wã lɛgsg gɛɛla tɩ. Tõnd sʋka sẽn be Houston Texas 810 Richmond Ave, la tõnd sẽn mɑɑnd yɩɩlem wã mɑɑndɩ yaa vɩɩɩs t’a maan, la tõnd kɩɩlem tɩrg yɩɩlem sayɛnsɩ maan mɑnda. Sã n tɑɑr tɩ, tõnd mɑɑnd tõnd bãngr la tõnd yɩɩl tɩ kɩɩdemd neb nins sẽn be Burkina Faso Region Centre-Est tɩ wɛɛngẽ – rɑ yaa tɩ tɩlem bɩ tãag me, la yaa tɩ tʋʋlg zug will bɩɩb zĩig t’a kareng zaabgã bɩ t’a sõngd t’a nɑ n tʋme nins sẽn sõmblem ne tɩrg sõsg nins sẽn be neb wubgr pʋgẽ wã.

Tõnd sẽn dĩina wã ma yaa wotoogo lɛgtã yɩɩgr me, la yaa neb sẽn lebg n nɑng tõog t’a maan, sayɛnsɩ sẽn wɑ, la sɩd-gãag t’a yɩɩlem wã sẽ yaa bãngr buudum n tɑɑre. Texas-Mexico dɑnd sẽn yɩɩsg tɩrgã goamã sʋka, Houston tuumb tuumd sẽn be sayɛnsɩ pʋgẽ wã, la sã n tɑɑr tɩ, Tenkodogo, Koupéla, la Region Centre-Est zãng zãng taoorã, tõnd sɩd-gãag t’a bʋʋd bãngr sẽn yaa tɩɩm n dɩk a yɩɩlem pʋgẽ, sayɛnsɩ sẽn vʋʋg a sɩdã, la yɩɩlg sẽn yaa yolsg zugu.

Tõnd Tʋʋl zugr: Bentley yɩɩlgã yembr la Tɩrg Sayɛnsɩ tɩɩm

Bɩ tõnd wa ne t’a bʋʋd cannabinoids yɑlã bee terpenes, fɩɩk tɩ tõnd bʋʋd sẽn gilg tõnd sẽn tʋmdã wã yɩlgame. Wã ma yaa zĩndgr me – yaa tõnd sẽn yi, tõnd sɩdã, la tõnd yʋ-yʋʋgr nud-bal.

Bentley yaa pitbull, maa me yaool n yaa laafɩ wʋsg rãmb me, la yaa bark. A waoog laafɩ wã wʋsgo, a sẽn dɩk ne a kobre zĩigã maanee. Bʋʋgre sẽn be wʋsgo wã pʋg yemba fʋɩ ne yembr-yikr sẽn yaa wʋm-taoor bala: A yi a nɑ n tʋɩ yaa yɩɩsgo bala, tɩ kosg sẽn yaa bʋʋgre nins maansdã sẽ nɑ n sɩbg a miis-yikrã. La Jessica sẽn yaa sẽn kẽesd ne bark tɩɩma wã sẽn kõ-b ne sõngr soaba sẽn yeele: “F mam yãk weed sẽn gʋlsa woto wã la fo ma leb n wʋm CBD wã?”

Yʋʋr woto wã n dɩk sẽn yaa sayɛnsɩ sẽn bas ne sã n yi. Tõnd tuumda bark endocannabinoid systems, tõnd tuum kosg sẽn sãng-b lɑɑsã, la tõnd sãng sẽn na n le be tõnd CBD Golden Paste Recipe wã:

• 1/2 tas organic turmeric baoodo
• 1 tas koɛɛga
• 1/3 tas unrefined organic coconut kɩɩsga
• 1-2 cuilleres wiligd sẽn kɩɩsg black poivre (sẽn yaa sõma t’a sãng a nɑ n dɩk kẽngẽ)
• CBD kɩɩsga sẽn boond ne koɛɛg la beoogo

Rẽndã n wʋm t’a maan bʋʋgre sẽn dɩkẽ. Bentley, sẽn dɩke kiuug gãeeg wʋsgẽ, a tigim a zug la a wa, la a kõ tõnd a tennis ball sẽn yaa a soaba. A vɩɩka yʋʋr pii la a ku, la a sã n yi a nɛrega a yaa wae. Saab woto wã, tõnd sãngd kosg sẽn yaa tʋʋmde neurodegeneration, dementia, glaucoma, la arthritis tɩ – b sẽn kɩt tɩ Bentley n tuum-b tɩ le bee t’a sẽn sãng-b. Formules wã n da le be tõnd sẽn maan tɑoor fãa zugr sã n ta tɩ.

Gilg-yɩɩl wã mii da t’a yaa sɩd sẽn yaa sõngr: vɩɩ-yɩɩlã, tɩrgã kõ sãrgã sẽn yaa t’a na n dɩk tɩ sẽn yaa b sẽn maanda tɩ. Tõnd tʋʋlã yaa t’a tuum yembr wã ne sayɛnsɩ sẽn kɩt tɩ, tɩ yɑool-n-taar ne sɩd minim, la sẽn yaa minim tɩ wa ne sor t’a tʋʋm nins fãa.

Cannabis, Hemp, la Bɩɩb Legal Landscape bãngr

Cannabis yaa tɩrg sẽn yaa neb sẽn tʋmd yembr sẽn be, ne zut sẽn kõ sɩd t’a tʋmda sẽn wa n yi yʋʋr 12 000. Tɩrgã tara yamã yaa 540, sẽn kõe t’a tara cannabinoids sẽn yi tɩrgã pʋgẽ sẽn yaa lall ne 0.3% Delta-9 THC n gʋls tɩ sẽn yaa a sẽn kõe – 100, lall sẽn tʋme ne mammalian endocannabinoid system – bãng-biig sẽn be vertebrates fãa pʋgẽ sẽn yaool n tʋme ne yel-kaoodo, yam-yaogrã, yɩlem, rũmsã, immune system tʋʋmã, gofnegrã, gʋlsgrã, la wʋsg sẽn tɩʋmdã.

Sẽn yaa sõmblem Legal la yɩlem: Cannabis sɑɑk-kãngsã wã wʋʋsd yɩɩ-yɩɩl bɩɩb zĩig fãa. Burkina Faso, cannabis wã ma tara sɑɑk-kãng t’a tɩ yɩɩm naong tɩ, ne sẽn tara, sẽn tʋmd, la sẽn dɑɑs-b tɩɩmã sẽn yɩɩm t’a dag ne sɑɑk-kãng sõngr. Zĩis wã yaa yɩɩlem la sayɛnsɩ bala, akanesg yelkã ne sẽn yaa research findings tɩ ma yɩɩsg a sẽn yaa legal tʋʋmã bee sẽn be yʋngã pʋgẽ wã.

2018 Amerika Farm Bill n da sãng t’a yɩɩma hemp (cannabis sẽn tara sẽn kõe t’a yɩ 0.3% Delta-9 THC n gʋls a sẽn yaa tɩ) la marijuana. Legislations wã n da tʋme t’a maan research, tʋɩmde, la hemp n yi tɩ sẽn tara kosg tɩ le be tɩ le tara cannabinoids tɩ le yɩ CBD, CBG, CBN, la THCa sẽn yaa acidic, ne sẽn yɩɩm t’a maan yam-yɩgr. Yaa sẽn be sayɛnsɩ la legal framework pʋgẽ wã tɩ tõnd research la kosg lɛgdb tʋʋmdã sã n tʋme.

Endocannabinoid System: Sẽ yaa sõngr tɩ Sayɛnsɩ Wã Mii

Sẽn wã 1990s wã pʋgẽ sẽn wa n yi research sẽn maan tɩ THC sẽn tʋʋmd kõoglgẽ wã yɩlgame la, endocannabinoid system (ECS) wã sã n tɑɑr tɩ b sã n dɩk t’a yaa bãng-biig sẽn be vertebrates fãa pʋgẽ – neb, wɑʋ�ʋsg, gʋlsã, la bark sẽn be wʋsg pʋsẽ. ECS wã ma bood n yi cannabis wã; me cannabis wã yamã n da leb n tʋme ne bãng-biig wã sẽn da yɩ n be pʋgẽ wã sẽn da yɩ n koɛɛga sẽn wa n yi yʋʋr 600 million.

ECS wã tara sẽn yaa a zug pʋga:

1. CB₁ Receptors: Sẽn be sõor kõoglgẽ la central nervous system, sẽn tara a koɛɛega sẽn be hippocampus, basal ganglia, la cerebellum. Tʋʋm wã pʋga: yel-kaoodo tʋʋmdã, yam-yaogrã tʋʋmdã, yɩlem tʋʋmdã, motor control, la rũmsã.
2. CB₂ Receptors: Sẽn be sõor baoodo immune cells pʋgẽ, peripheral nervous system, la zĩig sẽn yɑɑ koɛɛgã. Sẽn koɛɛega sẽn be spleen, tonsils, la immune tissues. Tʋʋm wã pʋga: gʋlsgrã tʋʋmdã, immune response tʋʋmdã, la peripheral yel-kaoodo tʋʋmdã.
3. Endocannabinoids: Bãɛẽ mii sẽn yaa cannabis sẽn yɩɩs n yi a mii zugu. Anandamide (Sanskrit “ananda” sẽn gʋls tɩ bɩɩɩbsgo) wã tʋʋmd yam-yaogrã, yel-kaoodo, la rũmsã. 2-AG (2-Arachidonoylglycerol) yaa endocannabinoid sẽn koɛɛega la yaa agonist sẽn be CB₁ la CB₂ receptors fãa pʋgẽ.
4. Metabolic Enzymes: FAAH wã maand anandamide, MAGL maand 2-AG. Sẽn kɩt tɩ, CBD wã bɩɩs FAAH, sẽn zembd anandamide sẽn yaa bãɛɛ mii wã sẽn be bõn-kõngẽ pʋgẽ.

System wã yaa sẽn yaa sõngre sẽn koɛɛega sẽn wa na n yã n wã neb physiology pʋgẽ, sẽn vʋʋg tɩ cannabis sẽn yi tɩrgã wã sẽn maand tʋʋm wʋsg tɩ – b tʋʋmd ne system sẽn yaa zug sẽn tʋʋmd tɩ b tara bãng-biig sẽn tara (homeostasis).

Cannabinoid Sayɛnsɩ yikr kãngr

Tetrahydrocannabinolic Acid (THCa) – Sẽn Ma Yɩɩs Yɩɩm t’a Maan Yɩɩ-yɩgr

Molecular Formula: C₂₂H₃₀O₄

THCa yaa acidic, sẽn yɩɩm t’a tɩ maan yɩɩ-yɩgr la sẽn na n le yi a zug n kẽng Delta-9 THC. Cannabis sẽn yɩɩsg tɩ, cannabinoids sẽn be wʋsg yɩɩma 95% be a acid forms wã pʋgẽ. THCa wã lebg n be THC sẽn tara yɩɩ-yɩgrã ne decarboxylation – sẽn yaa tʋʋm sẽn pʋg ne wεεng (sẽn paase 220°F/104°C) sẽn yi carboxyl group (COOH) n kẽ CO₂. Lebg-yikre wã sã n tʋme sẽn yaa 87.7% sã n wεɛnga.

NIH Research sẽn wa (2023-2024) sẽn vʋʋg:

• THCa yaa PPARγ receptor agonist sẽn tara tɩɩm, sẽn gʋʋsd kõoglg cells t’ɑ ma waoog oxidative stress.
• Tʋʋmd kãeem sẽn be anti-inflammatory activity sẽn be colon inflammation models pʋgẽ ne COX-2 inhibition.
• Sẽn sãng n maand tɩ Alzheimer’s sẽn yɩɩma mouse models.

Dual-Pathway Sayɛnsɩ: THCa kõ will tɩ sẽn yaa wʋsg sẽn tara yembr. Sẽn yɩɩs tɩ b naand tɩ kõ sõngr sẽn yɩɩm t’a tɩ maan yɩɩ-yɩgr ne TRPA₁ receptor activation (Kᵢ = 12.3 µM), sẽn kõ anti-nausea, anti-inflammatory, la neuroprotective effects. Sẽn wεngdã lebg n kẽ Delta-9 THC ne decarboxylation, sẽn kõ yɩɩ-yɩgr effects fãa. Woto n yaa sãng-yikre sẽn yaa zug sẽn be sẽn tara yembr zug sẽn tʋmd a maanã.

Cannabidiol (CBD) – Cannabinoid Sẽn Tʋʋmdẽ

Molecular Formula: C₂₁H₃₀O₂ Molecular Weight: 314.46 g/mol

Sẽn wã 1940 ne Roger Adams sẽn be University of Illinois, CBD wã sã n tɑɑr tɩ a yaa cannabinoid sẽn tʋʋmd bɩɩb zĩig ne sẽn wa PubMed pʋgẽ 23 000. Amerika FDA wã vʋʋg Epidiolex® 2018 tɩ Lennox-Gastaut syndrome, Dravet syndrome, la tuberous sclerosis complex – cannabis sẽn yi tɩrgã sẽn yaa kosg sẽn yaa gom-biig sẽn yãk-b tɩ, tɩ ne a lobg yaa $30,000-$50,000 yuuni.

Research Validation:

• Harvard Medical School (Dr. Peter Grinspoon, 2024): CBD yaa “sẽn sõngda, sẽn yɩɩm t’a maan yɩɩsg yel-kaoodo” wã tɩ waoog wʋsg, insomnia, la chronic yel-kaoodo.
• National Academy of Sciences (2017): Review sẽn maan 17,722 studies wã tara “substantial evidence” wã tɩ chronic yel-kaoodo sõngr.
• Neurotherapeutics (2015): Sẽn yaa sõor preclinical evidence wã tɩ waoog wʋsg disorders sẽn kõe tɩ GAD, PTSD, panic disorder, social anxiety, la OCD.

Sẽn yaa sõmblem Safety sẽn yete: CBD wã bɩɩs cytochrome P450 enzymes (CYP2C9, CYP2C19, CYP3A4), sẽn maand yel-wʋsg tɩ b pʋʋsd ne kosg tɩ le yɩ warfarin (sẽn zembd bleeding risk), benzodiazepines (sẽn kõ tɩ b gof n zĩind), seizure kosg (clobazam, valproate), la immunosuppressants (tacrolimus, cyclosporine).

Cannabigerol (CBG) – “Mɑ Cannabis”

Molecular Formula: C₂₁H₃₂O₂

CBG wã wa a “mɑ” sẽn yete tɩ cannabinoids nins fãa sẽn yi a acidic precursor, CBGa zug. A sã n koɛɛega sẽn be sẽn gʋls tɩ a yɩ 1% sẽn be cannabis sẽn koɛɛg tɩrgã pʋgẽ, sẽn maand tɩ a yaa sẽn wʋmda la sẽn tara yɩɩla tɩ research.

Washington State University (2024) Double-Blind Study (N=34):

• 20mg CBG n maand waoog wʋsgã gʋʋsgo pʋsgo.
• Sẽn vʋʋg memory ENHANCEMENT effects – sẽn yaa sẽn gʋls tɩ THC memory-impairing reputation.
• Sẽn vʋʋg antibacterial efficacy ne MRSA ne bacterial membrane sẽn basdã.
• Tõnd PEACE Gummies wã tara 150mg pharmaceutical-grade CBG – 7.5x clinical sẽn vʋʋg dose.

Research sẽn paase (NIH 2024): CBG gʋʋsd t’ɑ ma waoog amyloid-beta toxicity (Alzheimer’s pathology), gʋʋsd neuroinflammation la oxidative stress, la yɩ GABA reuptake inhibition sẽn yɩɩma benzodiazepines la yɩɩm t’a maan addiction bee withdrawal risks.

Cannabinol (CBN) – Tɩrg Sõngr Sẽn Sõng Tɩ B Gof Ne

Molecular Formula: C₂₁H₂₆O₂

Sẽn yɩ n yi THC degradation ne sẽn tara a yuun la oxidation, CBN wã sã n yã n wa n yaa sẽn tɩ tara sɩd t’a sõng tɩ b gof n zĩind ne tɩrg sõngr.

University of Sydney (2024) / Oxford Academic (April 2024):

• Sẽn yaa yell sẽn yaa sõor sẽn vʋʋg tɩ a zembda BOTH NREM la REM gofnegrã sẽn be animal models.
• Effects sẽn yɩɩma zolpidem (Ambien).
• 11-OH-CBN metabolite wã vʋʋg CB₁ receptor effects sẽn tara tɩɩm.
• Neb randomized controlled trial (N=1000+): 50mg CBN sẽn vʋʋg gofnegrã ne placebo.

Cannabichromene (CBC)

Molecular Formula: C₂₁H₃₀O₂

Sẽn wã 1966, CBC wã yaa cannabinoid sẽn yaa a naas sẽn koɛɛega sẽn be chemovars wʋsg pʋgẽ. Yɩɩ-yɩɩl tɩ THC la CBD, a ma ne CB₁/CB₂ receptors me la a tʋmd TRPV₁ la TRPA₁ receptors sẽn zembd anandamide sẽn yaa bãɛẽ mii wã sẽn be bõn-kõngẽ pʋgẽ.

NIH Research (2024): CBC wã sãngd ne maturation nins sẽn be adult neural stem progenitor cells (NSPCs), kõsda akanesg kõoglg cell sẽn be hippocampus pʋgẽ, la zembda neuronal markers ne anandamide reuptake inhibition.

Synergy Sẽn Wã: 2:1 ratio CBD n yi CBC sẽn vʋʋg anti-tumor effects sẽn tara tɩɩm sẽn be koglg nins sẽn be head la neck squamous cell carcinoma cells pʋgẽ t’a yɩɩma compost tɩ le be.

Delta-8 THC – Sẽn Yɩɩm t’a Tɩ Maan Yɩɩsg sẽn waoog

Molecular Formula: C₂₁H₃₀O₂ (isomer sẽn yi Delta-9 THC)

Sẽn sã n tʋme sẽn yaa bãɛẽ mii sẽn be trace amounts, Delta-8 sẽn koɛɛega yaa sẽn maan n yi CBD ne isomerization. A yɩɩma 60% tɩ a yaa Delta-9 THC sẽn tara tɩɩma ne side effect profile sẽn yɩɩma.

Journal of Cannabis Research (2022) Survey (N=521 sẽn dɩk ne 38 states):

• 74% sẽn yet t’a ma tara waoog wʋsgo yɩɩ-yɩɩl tɩ Delta-9 THC.
• 83% sẽn yet t’a ma tara paranoia.
• 1995 Pediatric Study: 100% efficace sẽn sõngd t’a ma dɩk chemotherapy sẽn maand vomit sẽn be bi sẽn tara 3-13 yuuni, ne ZERO psychoactive effects sẽn yet sẽn be pediatric sẽn tara yembr wã.

Cannabinoid Research sẽn paase

THCV (Tetrahydrocannabivarin) – Journal of Cannabis Research (2020):

• Gʋʋsd rũmsã, zembd satiety, zembd energy metabolism.
• Gʋʋsg fasting plasma glucose concentrations.
• Ma tara adverse effects sẽn vʋʋg rimonabant, sẽn kãend t’a yɩ sẽn yaa sõma tɩ b tʋʋmd-b metabolic conditions.

HHC (Hexahydrocannabinol) – UCLA Study (2023):

• Be t’a yaa isomers sẽn yaa yiibu ((9R)-HHC la (9S)-HHC) ne tʋʋm sẽn yɩɩma.
• (9R)-HHC sẽn yɩɩma Delta-9 THC receptor binding.
• A pʋʋs n yaa sẽn tara yɩɩla colon cancer la ocular hypotony research.

THCo Acetate – University of Michigan Safety Study (2023):

• A pʋʋs n yi toxic ketene gas sã n wεnga (340°C/644°F).
• Sẽn pʋʋs n ku bude 5 ppm, sẽn tʋʋmd ne EVALI (e-cigarette bee vaping product use-associated lung injury).
• Tõnd kẽesda ne sẽn yaa sõma consumption methods (sublingual/edibles) sẽn yɩɩma wεngd inhalation wã sẽn na n maan yel-kaoodo n ma kosgr wã.

Entourage Effect: Sẽ yaa sõngr tɩ Full-Spectrum Mii

Entourage effect theory sẽn da yɩlgẽ, Dr. Raphael Mechoulam la Dr. Shimon Ben-Shabat n da tʋme 1998, sẽn yete tɩ cannabis compounds wã tʋʋmdã sõmda sẽn be yemblsgo tɩ sẽn be zãnsgo. Research sẽn wa na n yã n vʋʋg wã sẽn vʋʋg wã sayɛnsɩ:

Johns Hopkins University (2024) Double-Blind Study (N=20):

• 15mg D-limonene + 30mg THC n gʋʋs waoog wʋsgã ne 54.8%.
• Study wã n da kõ clinical proof sẽn be entourage effect wã – sẽn yete tɩ terpenes sẽn lebg n maand THC effects.
• Drexel University (2024) sãngame ne yele woto wã ne waoog wʋsg la paranoia sẽn gʋʋsdã.

University of Arizona (2024) NIH-Funded Research (Award R01AT011517):

• Tuumda 5 terpenes tɩ yel-kaoodo sẽn sõng sẽn ne mouse models.
• β-Caryophyllene vʋʋg morphine-equivalent analgesic effects ne CB₂ receptor activation.

MDPI Research (2024): CBG + CBD co-administration sẽn vʋʋg anti-inflammatory properties pʋsgo sẽn yɩɩma compost sẽn be wʋsg wã, sẽn gʋʋsd TNF-α sẽn zembd IL-10 la IL-37 anti-inflammatory cytokines.

Woto wã vʋʋg tɩ sẽ yaa sõngr tɩ full-spectrum formulations tɩ le yɩ tõnd 6-cannabinoid RSO (ne 5% live terpenes) sẽn tʋʋmd sõma sẽn yɩɩma isolated compounds tɩ le yɩ Epidiolex® (pure CBD) bee Marinol® (synthetic THC).

Terpene Therapeutics: sẽn wa yẽ Cannabis

Terpenes yaa yam sẽn maan yãnde sẽn be tɩrg fãa pʋgẽ, sẽn tʋʋmd tɩ a yɩ n tara yãnd-n-wεεng la yam-yaogr. Cannabis tara terpenes sẽn paase 200 sẽn sõng n maand therapeutic effects:

β-Caryophyllene: Terpene sẽn yaa yi la sẽn tʋme ne CB₂ receptors (ne sẽn yɩɩm t’a tɩ maan yɩɩ-yɩgr). Gʋʋsd pro-inflammatory mediators (TNF-α, IL-1β, IL-6, NF-κB). Research vʋʋg tɩ BCP + CBD combination yaa sẽn tara tɩɩm skin gʋlsgr tɩ sẽn yɩɩma sẽn be wʋsg wã, ne neuroprotective effects sẽn be Parkinson’s la Alzheimer’s models (ne CB₂, sẽn yɩɩma THCa PPARγ pathway).

Limonene: Tʋʋmd ne GABA receptors sẽn kõ tɩ b gof n zĩind. Johns Hopkins (2024) vʋʋg 54.8% waoog wʋsg gʋʋsgo sã n tara THC. Neb sẽn yi surgery sẽn hʋʋl linalool-rich lavender kɩɩsga soabã sẽn so tɩ b ma tara morphine, ne sẽn yaa sõmblem yʋʋr yel-kaoodo pʋgẽ la sẽn pʋʋs n lebg n maand Alzheimer’s pathological hallmarks.

Myrcene: Terpene sẽn koɛɛega sẽn be cannabis strains wʋsg pʋgẽ, ne sedative properties, analgesic effects (sẽn zembd THC yel-kaoodo gʋʋsgo), anti-inflammatory la antioxidant activity. Ma maand tolerance la zembd THC blood-brain barrier permeability.

Linalool: Sẽn da lagem ne lavender, tʋʋmd ne GABA receptors sẽn kõ tɩ b gof n zĩind. Sẽn vʋʋg tɩ a pʋʋs n lebg n maand Alzheimer’s pathological hallmarks sẽn be preclinical models.

Rick Simpson Legacy la RSO Modern Evolution

Rick Simpson, Kanada sẽn yaa engineer, wã cannabis kɩɩsgã therapeutic potential 2003 sã n a sõng t’a basal cell carcinomas ne topical applications. A “Run From The Cure” documentary (2008) n da dɩk global movement, tɩ rɩ a tuumã tʋʋm legal frameworks sẽn yi, sẽn da tʋme t’a yi Canada n yi.

Simpson 60-Gram Protocol:

• Dɩko: 60 grams RSO sẽn naand 90 wãkate.
• Pʋgẽ: Will ne riz grain size doses (≈0.05mL) 3x dũni.
• Sẽn zembde n kẽ 1 gram dũuni sã n yi wãkate 6.
• Maintenance: 1-2 grams sẽn yi wʋsg buud wãk fʋɩ.

Tõnd Pharmaceutical-Grade Enhancement: Sẽn yɩɩsg Simpson vision, tõnd sãng RSO sayɛnsɩ ne:

• Legal compliance (2018 Farm Bill, <0.3% Delta-9 THC)
• Gãag formulation (16,590mg dɩko cannabinoids, 6-cannabinoid synergy)
• Laboratory verification (third-party test, COAs sẽn be)
• Pharmaceutical-grade manufacturing (ISO-certified clean rooms)
• Sẽn tara yembr sẽn tʋmd a sor (THCa dual-pathway technology)

Tõnd THCa Rick Simpson Oil Sublingual Formula ($129.99 tɩ 30mL):

• 16,590mg dɩko cannabinoids (553mg/mL)
• CBD: 4500mg (150mg/mL) – C₂₁H₃₀O₂
• Delta-8 THC: 6000mg (200mg/mL) – C₂₁H₃₀O₂
• CBG: 3000mg (100mg/mL) – C₂₁H₃₂O₂
• THCa: 1500mg (50mg/mL) – C₂₂H₃₀O₄
• CBN: 750mg (25mg/mL) – C₂₁H₂₆O₂
• CBC: 750mg (25mg/mL) – C₂₁H₃₀O₂
• Delta-9 THC: 90mg (3mg/mL, <0.3% compliant) – C₂₁H₃₀O₂
• 5% Live Terpenes tɩ entourage effect
• Organic MCT kɩɩsga carrier tɩ bioavailability

Pharmacokinetics: Sublingual administration kõ 15-45 minute onset, 1-2 wãkate peak effects, 4-6 wãkate duration, la 13-19% bioavailability (sẽn yɩɩma oral routes sẽn yɩ 4-12%).

Functional Mushroom Synergy: Sẽn Na N Tʋʋm

Tõnd research wã ma tʋm yĩnga cannabis la tʋme functional mushrooms, tɩ tõnd da pʋʋʋsd synergistic formulations sẽn looge ancient wisdom ne modern sayɛnsɩ.

Proprietary Seshnz Formulations:

• Day Sesh Gummies: Lion’s Mane (40%) tɩ cognitive enhancement la neurogenesis, Cordyceps (30%) tɩ natural energy la athletic performance, Chaga (20%) tɩ antioxidant protection, Reishi (10%) tɩ adaptogenic balance.
• Night Sesh Gummies: Reishi (50%) tɩ relaxation la gofnegrã sõngr, Chaga (25%) tɩ yʋngã antioxidant protection, Lion’s Mane (15%) tɩ cognitive repair sã n gofã, Cordyceps (10%) tɩ recovery enhancement.
• Premium Seshnz Chocolate Bars: 5000mg proprietary functional mushroom blend sẽn be bar yembla, 100% organic fruiting bodies (ma me mycelium) sẽn be premium Belgian chocolate pʋgẽ.

Sayɛnsɩ Synergy: Mushroom beta-glucans zembd cannabinoid absorption ne gut laafɩ sẽn vʋʋgã, la mushroom la cannabis terpenes tʋʋmd yemblsgo tɩ therapeutic effects sẽn tara tɩɩmã. Lion’s Mane + CBD kõ combined neuroprotective la neurogenesis-promoting effects, la Reishi + CBN zembd gofnegrã sor la wʋsg adaptation.

Pharmaceutical Lobsg Bilgri: Economic Reality

Yuuni Lobsg Bilgri ne OilWell RSO (4 bottles/$519.96 yuuni):

• Epidiolex® (CBD): $30,000-$50,000 – OilWell yaa 57-96x tɩ a yaa sẽn tara yɩɩla
• Marinol® (Dronabinol): $12,000-$24,000 – OilWell yaa 23-46x tɩ a yaa sẽn tara yɩɩla
• Sativex® (THC:CBD 1:1): $7,200-$9,600 – OilWell yaa 14-18x tɩ a yaa sẽn tara yɩɩla
• Prescription Opioids: $4,800-$9,600 – Piig addiction la overdose risks
• Gofnegrã Kosg (Ambien): $1,800-$3,600 – Piig dependency risks

Economic reality wã vʋʋg tɩ sẽ yaa sõngr tɩ pharmaceutical-grade botanical alternatives sõmblem research consideration sẽn be appropriate legal frameworks.

Sor Yembr: Pharmaceutical-Grade Standards

Tõnd manufacturing protocols wã paase cannabis industry standards sẽn be tɩ, sẽn yɩɩma pharmaceutical-grade requirements:

Laboratory Testing Excellence:

• Sor Testing: HPLC/UHPLC analysis ±2% accuracy
• Heavy Metals Screening: ICP-MS testing sẽn be FDA detection limits
• Pesticide Analysis: 400+ compound screening ne LC-MS/MS la GC-MS/MS
• Residual Solvents: FDA Class 3 limits (<5,000 ppm) sẽn vʋʋge ne headspace GC
• Microbial Testing: Comprehensive pathogen screening sẽn kõe E. coli, Salmonella, Aspergillus
• Terpene Profiling: Dɩko analysis ne GC-MS tɩ authenticity
• Stability Testing: 24-wãkate shelf life validation ne accelerated aging studies

Manufacturing Infrastructure:

• ISO-Certified Clean Rooms (medical device manufacturing standards)
• Advanced HVAC Systems ne pharmaceutical-grade air filtration
• Automated Quality Control ne computer-controlled batch consistency
• Blockchain-verified chain of custody sẽn yi seed n kẽ analytical verification
• Nitrogen-sealed, UV-protected, oxygen-free packaging systems
• 60-wãkate minimum slow-cure methodology tɩ flower products

Tõnd Media Recognition la Mainstream Credibility

Tõnd vʋʋga ABC News segments wʋsg pʋgẽ, sẽn sãng mainstream media credibility:

ABC13 Houston Feature (September 16, 2019): “Yaa sẽn yaa neb yɩɩlg wʋsg, la rɑ segd neb naongo. Mam ma segd neb snake kɩɩsg. Mam ma segd neb vʋʋre, la research sẽn be pʋsẽ wã tɩ neb fɩɩk tɩ b bãng la b sã n tʋme la b tara version sẽn yaa sõma tɩ b na n base b yam-yikr tɩ b na n kõ a sɩd sor bee a maan sor.” – Colin Valencia

ABC13 Delta-8 THC Analysis (May 24, 2021): Sã n boond “Sẽ yaa sõngr tɩ soab na n wεng woto?” Colin kõlg: “Mam ma tɩɩm tɩ a yɩ a maan sor tɩ fo na n yɩ n yaa sẽn yɩɩg zugu. Fo pʋʋs n na n ba tɩ fo yɩ n yaa zugu.” – sẽn vʋʋg tõnd candid approach kosg effects.

ABC13 COVID-19 Vaccine Incentive (August 20, 2021): Tõnd sãngd $35,000 sẽn yaa kosg sẽn yaa pʋgẽ (1,000 special edition caviar pre-rolls) Houston sẽn tara yembr sẽn tɩʋmd vaccine soabã, sẽn kãesd tɩ community laafɩ yɩɩma lobsg. “Tõnd wʋm tɩ Houston n laf sẽn yɩɩma pʋsẽ. Tõnd ma yaa bʋʋgr. Tõnd ma yaa sẽn bãng woto. Tõnd ma tara political agenda. Wa la fo tʋme sã n yaa sõmblem fo la fo yam-yikr soabã!”

ABC13 Marijuana Pardon Policy (October 8, 2022): Colin da bʋʋd a marijuana charges sẽn da be tɩ a tʋʋmd criminal justice reform: “Fo waog wʋsg ne sõngr, loans, la banking, mam yete ne tʋʋm fãa… Mam wʋm tɩ neb ma waog ne woto sã n paase.”

Features wã vʋʋg tõnd minim tɩ tʋʋm ne minim, yɩɩlem, la will tʋʋmd legal frameworks.

Region Centre-Est Context: Yɩɩlg la Economic Yel-kaoodo

Tõnd bãng tɩ Burkina Faso Region Centre-Est – sẽn kõ Tenkodogo, Koupéla, Pouytenga, la taoor sẽn dɩk ne wã – tara a yɩɩlgã, economic, la legal landscape sẽn ne cannabis, tõnd sɩd-gãag tɩ sẽn yaa universal principles sẽn be wʋsg tʋme:

Agricultural Wisdom: Region Centre-Est tara agricultural yɩɩlg sẽn yɩɩsg, sẽn yaa sorghum, millet, maïs, la cotton tʋɩmd. Agricultural bãngr wã yaa zug tɩ tɩrg sayɛnsɩ bãngr, tʋɩm techniques, la botanical extraction principles bãngr sẽn wa yẽ specific crops.

Traditional Medicine Systems: Yɩɩ-yɩɩl tɩ Africa taoor wʋsg, Burkina Faso tara traditional medicine practices sẽn tʋme local botanicals. Cannabis wã ma yaa sẽn yɩɩsg Burkinabé medicine pʋgẽ, la principle sẽn yaa t’a tuum plant-based therapeutics research sẽn lagem ne global scientific inquiry ethnobotany la pharmacognosy.

Economic Context: Agriculture sẽn tʋʋmd neb sẽn yɩɩma 80% Burkina Faso, t’a tara bãngr sẽn be tɩrg tʋɩmd, harvest timing, processing techniques, la natural product value chains sẽn pʋʋs sẽn tʋme t’a tʋʋmd botanical industries sẽn be appropriate legal frameworks.

Research Accessibility: Internet sẽn yi zug Burkina Faso (sẽn yɩɩma 22% national ne sẽn paase urban centers tɩ le yɩ Ouagadougou la Bobo-Dioulasso), bãngr global scientific literature la cannabinoid research sẽn be wã sã n tɑɑr tɩ a maana tɩ research, healthcare professionals, la sẽn tara yɩɩlem sẽn be Region Centre-Est pʋgẽ.

Yɩɩl Tʋʋl Tɩ Global Bãngr

Tõnd sẽn maan tɩ tõnd bʋʋ zĩis wã ne Region Centre-Est wã yaa yɩɩlem bala:

1. Sayɛnsɩ Literacy: Cannabis biochemistry yalg n yi cultural stereotypes.
2. Research Awareness: Sẽn vɩɩsg peer-reviewed studies sẽn yi institutions tɩ le yɩ Johns Hopkins, Washington State University, NIH, la University of Sydney.
3. Pharmacological Bãngr: Sẽn vʋʋg mechanisms of action, receptor interactions, la metabolic pathways.
4. Sor Standards Yɩɩlem: Sẽn vʋʋg pharmaceutical-grade manufacturing protocols sẽn pʋʋs sẽn sõng tɩ botanical industry.
5. Economic Analysis: Kõ lobsg-bilgri sẽn be pharmaceutical la botanical approaches.
6. Regulatory Awareness: Sẽn vʋʋg global legal landscapes sẽn yɩɩma la sẽn tʋʋmd ne universal scientific principles.

Tõnd Minim Tɩ Tʋʋm ne Will Communication

Tõnd tʋʋmd ne principles sẽn yaa minim:

Anti-Hallucination Protocol: Tõnd ma maan yel-wʋsg tɩ kosg yʋʋr, strain genetics, research findings, bee sẽn yaa bark yele. Yembr fãa lagem ne sources sẽn pʋʋs sẽn vʋʋg bee tõnd sẽn tʋme.

Yɩɩlem Focus: Tõnd kãesda tɩ vʋʋg biochemical mechanisms, research methodologies, la sor standards sẽn yɩɩma promotional messaging.

Yɩɩlg Yɩɩsg: Tõnd vʋʋg la tõnd yɩɩsg Burkina Faso national sɑɑk-kãngsã, cultural values, la traditional bãngr systems la sẽn bʋʋd global scientific perspectives.

Minim: Tõnd bʋʋda tõnd formulations, testing protocols, la business practices, sẽn sɩd-gãag tɩ sẽn yaa sɩd decisions sẽn so tɩ tara zĩis dɩko.

Compliance: Tõnd tʋʋmd sẽn kɩt tɩ wa ne Amerika federal la Texas state sɑɑk-kãngsã sẽn ne hemp sẽn yi tɩrgã wã kosg yɩlgame, la tõnd sãngd bɩɩb zĩig sẽn be pʋgẽ fãa n yɩɩsg b national regulations.

Tɩrg Sayɛnsɩ Research Sẽn Na N Tʋʋm

Bɩɩb research sẽn be plant therapeutics pʋgẽ sẽn zembde, taoor wʋsg vɩʋʋg sãrg sẽn yaa sõma:

Precision Formulations: Cannabinoid la terpene ratios sẽn lebg n maand specific therapeutic applications sẽn yi emerging clinical evidence.

Delivery Optimization: Bioavailability sẽn vʋʋg ne nanotechnology, liposomal encapsulation, la advanced carrier systems.

Synergy Exploration: Sẽn be cannabis compounds, functional mushrooms, la tɩrg sẽn be wʋsg tɩ le yɩ curcumin, piperine, la omega-3 fatty acids.

Sustainability Integration: Sẽn na n sãng regenerative agricultural practices, carbon-neutral extraction methods, la circular economic models tɩ botanical industries.

Global Collaboration: Sẽn na n sãng international research partnerships sẽn yɩɩsg legal frameworks sẽn yɩɩma sẽn zembd universal scientific bãngr.

Pʋgbgã: Bãngr Yaa Zug Tɩ Sẽn Na N Be

Sẽn yi Texas Medical Center sẽn be Houston n kẽ agricultural taoor sẽn be Region Centre-Est, tõnd sɩd-gãag tɩ tɩrg sayɛnsɩ tɩɩmã sõngd tɩ b maan neb wʋsgo. Tõnd yolgr – sẽn yi Bentley sẽn yɩɩm t’a na n lebg n vɩɩ n kẽ pharmaceutical-grade manufacturing n kẽ global yɩɩlem outreach – vʋʋg sɩd-gãag sẽn yaa zug: sã n tõe tɩ tõnd looge yolsg ne sayɛnsɩ sẽn kɩt tɩ, traditional wisdom ne modern technology, la sẽn tʋme ne peer-reviewed research, tõnd maand sẽn sõngd neb fãa.

Tõnd bãng tɩ Burkina Faso legal framework sẽn ne cannabis wã yɩɩma yɩɩ-yɩɩl sẽn yi policies sẽn be taoor wʋsgẽ. Zĩis wã ma yete tɩ b lebg n maan national sɑɑk-kãngsã bee cultural values. Me, a kõ comprehensive scientific zĩis tɩ yɩɩlem tɩ, sẽn vʋʋg tɩ bãngr mii tara yɩɩla mɑ t’a tʋme sẽn wa.

Region Centre-Est, ne a agricultural heritage, yɩɩlem infrastructure sẽn vɩʋʋgdã, la sẽn be West African scientific taoor sẽn be pʋsẽ wã, vʋʋg tɩ a yaa akanesg sẽn tara yam sẽn sõng tɩ b tara zĩis sẽn yaa detalye, sẽn yaa sɩd, sẽn lagem ne scientific sẽn vɩʋʋg sẽn be emerging botanical research.

Mɑ bãng wã rẽnda sõngd academic study, healthcare practice, agricultural innovation, bee a sʋk tɩ sayɛnsɩ sẽn kãndã, tõnd yiisda tɩ tõnd bʋʋ tõnd sẽn bãng sẽn wa n yi yʋʋr wʋsg research, development, la real-world sẽn tʋme. Tɩrg sayɛnsɩ sẽn na n tʋʋmã dɩk ne sẽn tʋʋmd-b sẽn kɩt tɩ, b yɩɩsg a sẽn tara yel-wʋsgã, la b tʋme a sẽn bãng ne b wʋmd la sẽn yaa minim.

OilWell Cannabis – 810 Richmond Ave, Houston, TX 77006
Contact: (832) 416-2816 | [email protected]
Website: https://oilwellcbd.com/

Zĩis wã yaa yɩɩlem bala. Yembr wã ma vʋʋg food la drug authorities. Kosg wã ma yete tɩ a bãng, tɩ b tʋʋm, tɩ b yɩɩs, bee tɩ b gʋʋsd yel-wʋsg fãa. Bʋ fo bʋʋgr tɩ fo wa ne fo wellness regimen. Tʋʋmd ne local sɑɑk-kãngsã la regulations sẽn ne cannabis la hemp sẽn yi tɩrgã wã kosg.

ENGLISH

Cannabis Education & Cannabinoid Science for the Centre-Est Region: A Global Perspective from OilWell Cannabis

Welcome to a new era of natural wellness and botanical science. We are OilWell Cannabis, Houston’s premier cannabis authority and a global leader in cannabinoid research, extraction, and pharmaceutical-grade product development. While our physical headquarters are at 810 Richmond Ave in Houston, Texas, our educational mission and passion for plant-based science know no borders. Today, we extend our knowledge and experience to the thoughtful residents of Burkina Faso’s Centre-Est Region—not with promises of availability, but with a commitment to global education about the remarkable cannabis plant and its potential role in human wellness.

Our story is not one of corporate expansion, but of personal transformation, scientific discovery, and a deep-seated belief that education precedes understanding. From the arid landscapes of the Texas-Mexico border to the research laboratories of Houston, and now to the vibrant communities of Tenkodogo, Koupéla, and throughout the Centre-Est Region, we believe in sharing knowledge that has been hard-won through experience, validated by science, and grounded in compassion.

The Foundation of Our Mission: Bentley’s Miracle and the Power of Botanical Science

Before we discuss cannabinoids or terpenes, we must share the story that defines everything we do. This isn’t marketing—it’s our origin, our truth, and our moral compass.

Bentley was a pitbull, not just a pet, but family. He faced life-threatening health challenges, completely paralyzed in his back legs. Every veterinarian delivered the same devastating verdict: euthanasia was the only humane option, as traditional pain medications would destroy his internal organs. But a question from a rescue worker named Jessica changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

That moment launched a desperate scientific inquiry. We studied canine endocannabinoid systems, researched pharmacokinetics, and developed what would become our CBD Golden Paste Recipe:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup unrefined organic coconut oil
• 1-2 teaspoons freshly ground black pepper (essential for absorption)
• CBD oil adjusted for weight and needs

The result defied veterinary prediction. Bentley, paralyzed for months, stood up, walked over, and brought us his favorite tennis ball. He lived ten additional years, passing naturally at age 20. During that decade, we developed specialized formulations for neurodegeneration, dementia, glaucoma, and arthritis—all tested and refined through Bentley’s lived experience. Those formulas became the foundation for every product we create today.

This story matters because it represents a fundamental truth: sometimes, nature provides solutions where conventional approaches reach their limits. Our mission is to explore these possibilities with scientific rigor, ethical transparency, and unwavering commitment to quality.

Understanding Cannabis, Hemp, and the Global Legal Landscape

Cannabis is one of humanity’s oldest cultivated plants, with archaeological evidence of its use dating back over 12,000 years. The plant contains over 540 chemical compounds, including more than 100 phytocannabinoids that interact with the mammalian endocannabinoid system—a biological network present in all vertebrates that regulates pain, mood, memory, appetite, immune function, sleep, inflammation, and stress management.

Important Legal Distinction: Cannabis laws vary dramatically worldwide. In Burkina Faso, cannabis remains illegal under national law, with possession, cultivation, and distribution subject to legal penalties. This content is purely educational and scientific, discussing biochemical compounds and research findings without suggesting legal use or availability in your region.

The 2018 U.S. Farm Bill created a distinction between hemp (cannabis containing less than 0.3% Delta-9 THC by dry weight) and marijuana. This legislation allowed for research, cultivation, and commerce of hemp-derived products containing other cannabinoids like CBD, CBG, CBN, and THCa in their acidic, non-psychoactive forms. It’s within this scientific and legal framework that our research and product development occurs.

The Endocannabinoid System: Why This Science Matters

Discovered in the 1990s through research on how THC affects the brain, the endocannabinoid system (ECS) is now recognized as a fundamental biological system present in all vertebrates—humans, dogs, cats, and many other animals. The ECS wasn’t named after cannabis; rather, cannabis compounds were found to interact with this pre-existing biological system that had been evolving for approximately 600 million years.

The ECS consists of four key components:

1. CB₁ Receptors: Primarily located in the brain and central nervous system, highest density in hippocampus, basal ganglia, and cerebellum. Functions include pain modulation, mood regulation, memory processing, motor control, and appetite.
2. CB₂ Receptors: Primarily found in immune cells, peripheral nervous system, and gut. Highest density in spleen, tonsils, and immune tissues. Functions include inflammation regulation, immune response modulation, and peripheral pain management.
3. Endocannabinoids: The body’s own cannabis-like molecules produced on demand. Anandamide (from Sanskrit “ananda” meaning bliss) regulates mood, pain, and appetite. 2-AG (2-Arachidonoylglycerol) is the most abundant endocannabinoid and a full agonist at both CB₁ and CB₂ receptors.
4. Metabolic Enzymes: FAAH breaks down anandamide, MAGL breaks down 2-AG. Interestingly, CBD inhibits FAAH, thereby increasing natural anandamide levels in the body.

This system represents one of the most important recent discoveries in human physiology, explaining why plant cannabinoids have such diverse effects—they’re interacting with a fundamental regulatory system that maintains biological balance (homeostasis).

Deep Dive into Cannabinoid Science

Tetrahydrocannabinolic Acid (THCa) – The Non-Psychoactive Precursor

Molecular Formula: C₂₂H₃₀O₄

THCa is the acidic, non-psychoactive precursor to Delta-9 THC. In raw cannabis, about 95% of cannabinoids exist in their acidic forms. THCa converts to psychoactive THC through decarboxylation—a process involving heat (above 220°F/104°C) that removes a carboxyl group (COOH) as CO₂. This conversion happens at approximately 87.7% efficiency when properly heated.

Recent NIH Research (2023-2024) reveals:

• THCa is a potent PPARγ receptor agonist, protecting brain cells from oxidative stress.
• Responsible for the majority of anti-inflammatory activity in colon inflammation models via COX-2 inhibition.
• Ameliorated Alzheimer’s-like features in mouse models.

Dual-Pathway Science: THCa offers patient-controlled experiences. Raw consumption provides non-psychoactive therapeutic benefits through TRPA₁ receptor activation (Kᵢ = 12.3 µM), offering anti-nausea, anti-inflammatory, and neuroprotective effects. Heated consumption converts to Delta-9 THC through decarboxylation, providing full psychoactive effects. This represents a fundamental innovation in patient autonomy.

Cannabidiol (CBD) – The Most Researched Cannabinoid

Molecular Formula: C₂₁H₃₀O₂ Molecular Weight: 314.46 g/mol

Discovered in 1940 by Roger Adams at the University of Illinois, CBD has become the most researched cannabinoid globally with over 23,000 publications on PubMed. The U.S. FDA approved Epidiolex® in 2018 for Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex—the first cannabis-derived prescription medication, though it costs $30,000-$50,000 annually.

Research Validation:

• Harvard Medical School (Dr. Peter Grinspoon, 2024): CBD is a “helpful, relatively nontoxic option” for anxiety, insomnia, and chronic pain.
• National Academy of Sciences (2017): Review of 17,722 studies found “substantial evidence” for chronic pain relief.
• Neurotherapeutics (2015): Strong preclinical evidence for anxiety disorders including GAD, PTSD, panic disorder, social anxiety, and OCD.

Critical Safety Note: CBD inhibits cytochrome P450 enzymes (CYP2C9, CYP2C19, CYP3A4), creating potentially serious interactions with medications like warfarin (increased bleeding risk), benzodiazepines (enhanced sedation), seizure medications (clobazam, valproate), and immunosuppressants (tacrolimus, cyclosporine).

Cannabigerol (CBG) – The “Mother Cannabinoid”

Molecular Formula: C₂₁H₃₂O₂

CBG earns its “mother” designation because all other cannabinoids derive from its acidic precursor, CBGa. It typically comprises less than 1% of mature cannabis plants, making it rare and valuable for research.

Washington State University (2024) Double-Blind Study (N=34):

• 20mg CBG produced significant anxiety reduction.
• Demonstrated memory ENHANCEMENT effects—the opposite of THC’s memory-impairing reputation.
• Validated antibacterial efficacy against MRSA through bacterial membrane disruption.
• Our PEACE Gummies contain 150mg pharmaceutical-grade CBG—7.5x the clinically proven dose.

Additional Research (NIH 2024): CBG protects against amyloid-beta toxicity (Alzheimer’s pathology), reduces neuroinflammation and oxidative stress, and produces GABA reuptake inhibition similar to benzodiazepines but without addiction or withdrawal risks.

Cannabinol (CBN) – Nature’s Sleep Aid

Molecular Formula: C₂₁H₂₆O₂

Formed from THC degradation through aging and oxidation, CBN has emerged as one of the most promising natural sleep aids.

University of Sydney (2024) / Oxford Academic (April 2024):

• First objective evidence demonstrating increases in BOTH NREM and REM sleep in animal models.
• Effects comparable to zolpidem (Ambien).
• The 11-OH-CBN metabolite demonstrates significant CB₁ receptor effects.
• Human randomized controlled trial (N=1000+): 50mg CBN significantly improved sleep versus placebo.

Cannabichromene (CBC)

Molecular Formula: C₂₁H₃₀O₂

Discovered in 1966, CBC is the second most prominent cannabinoid in some chemovars. Unlike THC and CBD, it doesn’t bind strongly to CB₁/CB₂ receptors but activates TRPV₁ and TRPA₁ receptors while increasing natural anandamide levels.

NIH Research (2024): CBC positively influences maturation of adult neural stem progenitor cells (NSPCs), promotes new brain cell formation in the hippocampus, and upregulates neuronal markers through anandamide reuptake inhibition.

Synergy Discovery: A 2:1 ratio of CBD to CBC demonstrated stronger anti-tumor effects in head and neck squamous cell carcinoma cells than either compound alone.

Delta-8 THC – The Reduced-Anxiety Alternative

Molecular Formula: C₂₁H₃₀O₂ (isomer of Delta-9 THC)

Occurring naturally in trace amounts, most Delta-8 is manufactured from CBD through isomerization. It’s approximately 60% as potent as Delta-9 THC with a markedly different side effect profile.

Journal of Cannabis Research (2022) Survey (N=521 across 38 states):

• 74% reported NO anxiety versus Delta-9 THC.
• 83% reported NO paranoia.
• 1995 Pediatric Study: 100% effective in preventing chemotherapy-induced vomiting in children ages 3-13, with ZERO psychoactive effects reported in these pediatric patients.

Additional Cannabinoid Research

THCV (Tetrahydrocannabivarin) – Journal of Cannabis Research (2020):

• Decreases appetite, increases satiety, up-regulates energy metabolism.
• Significantly reduces fasting plasma glucose concentrations.
• No adverse effects seen with rimonabant, suggesting potential as a safer alternative for metabolic conditions.

HHC (Hexahydrocannabinol) – UCLA Study (2023):

• Exists as two isomers ((9R)-HHC and (9S)-HHC) with different biological activities.
• (9R)-HHC similar to Delta-9 THC in receptor binding.
• May be valuable for colon cancer and ocular hypotony research.

THCo Acetate – University of Michigan Safety Study (2023):

• May release toxic ketene gas when heated (340°C/644°F).
• Potentially lethal at 5 ppm, implicated in EVALI (e-cigarette or vaping product use-associated lung injury).
• We emphasize safer consumption methods (sublingual/edibles) over heated inhalation for this compound.

The Entourage Effect: Why Full-Spectrum Matters

The entourage effect theory, first proposed by Dr. Raphael Mechoulam and Dr. Shimon Ben-Shabat in 1998, suggests that cannabis compounds work better together than in isolation. Recent research has validated this scientifically:

Johns Hopkins University (2024) Double-Blind Study (N=20):

• 15mg D-limonene + 30mg THC reduced anxiety by 54.8%.
• This study provided the first clinical proof of the entourage effect—specifically how terpenes modify THC’s effects.
• Drexel University (2024) corroborated these findings with similar anxiety and paranoia reduction.

University of Arizona (2024) NIH-Funded Research (Award R01AT011517):

• Studied 5 terpenes for pain-relevant properties in mouse models.
• β-Caryophyllene demonstrated morphine-equivalent analgesic effects through CB₂ receptor activation.

MDPI Research (2024): CBG + CBD co-administration significantly enhanced anti-inflammatory properties versus either compound alone, reducing TNF-α while increasing IL-10 and IL-37 anti-inflammatory cytokines.

This explains why full-spectrum formulations like our 6-cannabinoid RSO (with 5% live terpenes) often outperform isolated compounds like Epidiolex® (pure CBD) or Marinol® (synthetic THC).

Terpene Therapeutics: Beyond Cannabinoids

Terpenes are aromatic compounds found in all plants, responsible for distinctive scents and flavors. Cannabis contains over 200 terpenes that contribute significantly to therapeutic effects:

β-Caryophyllene: The ONLY terpene known to directly activate CB₂ receptors (without psychoactivity). Reduces pro-inflammatory mediators (TNF-α, IL-1β, IL-6, NF-κB). Research shows BCP + CBD combination is MORE effective for skin inflammation than either alone, with neuroprotective effects in Parkinson’s and Alzheimer’s models (via CB₂, different from THCa’s PPARγ pathway).

Limonene: Interacts with GABA receptors promoting relaxation. Johns Hopkins (2024) validated 54.8% anxiety reduction when combined with THC. Post-surgery patients inhaling linalool-rich lavender oil required significantly less morphine, with positive outcomes on nerve pain and potential to reverse Alzheimer’s pathological hallmarks.

Myrcene: The most abundant terpene in many cannabis strains, with sedative properties, analgesic effects (enhances THC pain reduction), anti-inflammatory and antioxidant activity. Does NOT create tolerance and increases THC blood-brain barrier permeability.

Linalool: Traditionally associated with lavender, interacts with GABA receptors promoting relaxation. Shows potential for reversing Alzheimer’s pathological hallmarks in preclinical models.

The Rick Simpson Legacy and Modern RSO Evolution

Rick Simpson, a Canadian engineer, discovered cannabis oil’s therapeutic potential in 2003 when he successfully treated his basal cell carcinomas with topical applications. His “Run From The Cure” documentary (2008) sparked a global movement, though his work operated outside legal frameworks, eventually forcing him into exile from Canada.

Simpson’s 60-Gram Protocol:

• Total: 60 grams of RSO consumed over 90 days.
• Start: Rice grain-sized doses (≈0.05mL) 3x daily.
• Gradual increase to 1 gram daily by week 6.
• Maintenance: 1-2 grams monthly indefinitely.

Our Pharmaceutical-Grade Enhancement: While respecting Simpson’s vision, we’ve advanced RSO science through:

• Legal compliance (2018 Farm Bill, <0.3% Delta-9 THC)
• Precise formulation (16,590mg total cannabinoids, 6-cannabinoid synergy)
• Laboratory verification (third-party tested, COAs available)
• Pharmaceutical-grade manufacturing (ISO-certified clean rooms)
• Patient-controlled potency (THCa dual-pathway technology)

Our THCa Rick Simpson Oil Sublingual Formula ($129.99 for 30mL):

• 16,590mg total cannabinoids (553mg/mL)
• CBD: 4,500mg (150mg/mL) – C₂₁H₃₀O₂
• Delta-8 THC: 6,000mg (200mg/mL) – C₂₁H₃₀O₂
• CBG: 3,000mg (100mg/mL) – C₂₁H₃₂O₂
• THCa: 1,500mg (50mg/mL) – C₂₂H₃₀O₄
• CBN: 750mg (25mg/mL) – C₂₁H₂₆O₂
• CBC: 750mg (25mg/mL) – C₂₁H₃₀O₂
• Delta-9 THC: 90mg (3mg/mL, <0.3% compliant) – C₂₁H₃₀O₂
• 5% Live Terpenes for entourage effect
• Organic MCT oil carrier for bioavailability

Pharmacokinetics: Sublingual administration provides 15-45 minute onset, 1-2 hour peak effects, 4-6 hour duration, and 13-19% bioavailability (higher than oral routes at 4-12%).

Functional Mushroom Synergy: The Next Frontier

Our research extends beyond cannabis to functional mushrooms, where we’ve pioneered synergistic formulations combining ancient wisdom with modern science.

Proprietary Seshnz Formulations:

• Day Sesh Gummies: Lion’s Mane (40%) for cognitive enhancement and neurogenesis, Cordyceps (30%) for natural energy and athletic performance, Chaga (20%) for antioxidant protection, Reishi (10%) for adaptogenic balance.
• Night Sesh Gummies: Reishi (50%) for relaxation and sleep support, Chaga (25%) for nighttime antioxidant protection, Lion’s Mane (15%) for cognitive repair during sleep, Cordyceps (10%) for recovery enhancement.
• Premium Seshnz Chocolate Bars: 5000mg proprietary functional mushroom blend per bar, 100% organic fruiting bodies (not mycelium) in premium Belgian chocolate.

Scientific Synergy: Mushroom beta-glucans enhance cannabinoid absorption through improved gut health, while mushroom and cannabis terpenes work together for amplified therapeutic effects. Lion’s Mane + CBD provides combined neuroprotective and neurogenesis-promoting effects, while Reishi + CBN enhances sleep quality and stress adaptation.

Pharmaceutical Cost Comparisons: The Economic Reality

Annual Cost Comparison vs. OilWell RSO (4 bottles/$519.96 annually):

• Epidiolex® (CBD): $30,000-$50,000 – OilWell is 57-96x more affordable
• Marinol® (Dronabinol): $12,000-$24,000 – OilWell is 23-46x more affordable
• Sativex® (THC:CBD 1:1): $7,200-$9,600 – OilWell is 14-18x more affordable
• Prescription Opioids: $4,800-$9,600 – Plus addiction and overdose risks
• Sleep Medications (Ambien): $1,800-$3,600 – Plus dependency risks

This economic reality underscores why pharmaceutical-grade botanical alternatives deserve serious research consideration within appropriate legal frameworks.

Quality Assurance: Pharmaceutical-Grade Standards

Our manufacturing protocols exceed typical cannabis industry standards, approximating pharmaceutical-grade requirements:

Laboratory Testing Excellence:

• Potency Testing: HPLC/UHPLC analysis ±2% accuracy
• Heavy Metals Screening: ICP-MS testing below FDA detection limits
• Pesticide Analysis: 400+ compound screening via LC-MS/MS and GC-MS/MS
• Residual Solvents: FDA Class 3 limits (<5,000 ppm) verified by headspace GC
• Microbial Testing: Comprehensive pathogen screening including E. coli, Salmonella, Aspergillus
• Terpene Profiling: Complete analysis via GC-MS for authenticity
• Stability Testing: 24-month shelf life validation with accelerated aging studies

Manufacturing Infrastructure:

• ISO-Certified Clean Rooms (medical device manufacturing standards)
• Advanced HVAC Systems with pharmaceutical-grade air filtration
• Automated Quality Control with computer-controlled batch consistency
• Blockchain-verified chain of custody from seed to analytical verification
• Nitrogen-sealed, UV-protected, oxygen-free packaging systems
• 60-day minimum slow-cure methodology for flower products

Our Media Recognition and Mainstream Credibility

We’ve been featured in multiple ABC News segments, establishing mainstream media credibility:

ABC13 Houston Feature (September 16, 2019): “It’s a lot of educating people, but not over-promising people. I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” – Colin Valencia

ABC13 Delta-8 THC Analysis (May 24, 2021): When asked “Why would someone want to smoke that?” Colin responded: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.” – demonstrating our candid approach to product effects.

ABC13 COVID-19 Vaccine Incentive (August 20, 2021): We donated $35,000 in free products (1,000 special edition caviar pre-rolls) to vaccinated Houston residents, prioritizing community health over profit. “We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this sh**. We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!”

ABC13 Marijuana Pardon Policy (October 8, 2022): Colin shared his past marijuana charges to advocate for criminal justice reform: “You face challenges with housing, loans, and banking, I mean with about everything… I would love to see people not get hurt for this anymore.”

These features represent our commitment to transparency, education, and responsible advocacy within legal frameworks.

The Centre-Est Region Context: Cultural and Economic Considerations

While we recognize that Burkina Faso’s Centre-Est Region—encompassing Tenkodogo, Koupéla, Pouytenga, and surrounding communities—has its own unique cultural, economic, and legal landscape regarding cannabis, we believe several universal principles apply:

Agricultural Wisdom: The Centre-Est Region has deep agricultural traditions, particularly in sorghum, millet, maize, and cotton cultivation. This agricultural knowledge represents a foundation for understanding plant science, cultivation techniques, and botanical extraction principles that transcend specific crops.

Traditional Medicine Systems: Like many regions in Africa, Burkina Faso has rich traditional medicine practices that utilize local botanicals. While cannabis isn’t traditionally prominent in Burkinabé medicine, the principle of investigating plant-based therapeutics aligns with global scientific inquiry into ethnobotany and pharmacognosy.

Economic Context: With agriculture employing approximately 80% of the workforce in Burkina Faso, there’s inherent understanding of plant cultivation, harvest timing, processing techniques, and natural product value chains that could theoretically apply to various botanical industries under appropriate legal frameworks.

Research Accessibility: As internet access expands throughout Burkina Faso (currently around 22% nationally with higher penetration in urban centers like Ouagadougou and Bobo-Dioulasso), access to global scientific literature and cannabinoid research becomes increasingly possible for researchers, healthcare professionals, and educated citizens in the Centre-Est Region.

Educational Mission for Global Understanding

Our purpose in sharing this comprehensive information with the Centre-Est Region is strictly educational:

1. Scientific Literacy: Demystifying cannabis biochemistry beyond cultural stereotypes.
2. Research Awareness: Highlighting peer-reviewed studies from institutions like Johns Hopkins, Washington State University, NIH, and University of Sydney.
3. Pharmacological Understanding: Explaining mechanisms of action, receptor interactions, and metabolic pathways.
4. Quality Standards Education: Demonstrating pharmaceutical-grade manufacturing protocols that could theoretically benefit any botanical industry.
5. Economic Analysis: Providing cost-benefit comparisons between pharmaceutical and botanical approaches.
6. Regulatory Awareness: Acknowledging diverse global legal landscapes while focusing on universal scientific principles.

Our Commitment to Responsible Communication

We operate with several unwavering principles:

Anti-Hallucination Protocol: We never fabricate product names, strain genetics, research findings, or company information. Every claim references verifiable sources or our direct experience.

Educational Focus: We prioritize explaining biochemical mechanisms, research methodologies, and quality standards over promotional messaging.

Cultural Respect: We acknowledge and respect Burkina Faso’s national laws, cultural values, and traditional knowledge systems while sharing global scientific perspectives.

Transparency: We openly share our formulations, testing protocols, and business practices, believing informed decisions require complete information.

Compliance: We operate strictly within U.S. federal and Texas state laws regarding hemp-derived products, and we encourage all global citizens to respect their national regulations.

The Future of Botanical Science Research

As global research into plant therapeutics accelerates, several areas show particular promise:

Precision Formulations: Tailoring cannabinoid and terpene ratios for specific therapeutic applications based on emerging clinical evidence.

Delivery Optimization: Enhancing bioavailability through nanotechnology, liposomal encapsulation, and advanced carrier systems.

Synergy Exploration: Investigating interactions between cannabis compounds, functional mushrooms, and other botanicals like curcumin, piperine, and omega-3 fatty acids.

Sustainability Integration: Developing regenerative agricultural practices, carbon-neutral extraction methods, and circular economic models for botanical industries.

Global Collaboration: Fostering international research partnerships that respect diverse legal frameworks while advancing universal scientific understanding.

Conclusion: Knowledge as the Foundation for Future Possibilities

From the Texas Medical Center in Houston to the agricultural communities of the Centre-Est Region, we believe in the power of plant science to address human challenges. Our journey—from Bentley’s impossible recovery to pharmaceutical-grade manufacturing to global educational outreach—reflects a fundamental belief: when we combine compassion with scientific rigor, traditional wisdom with modern technology, and personal experience with peer-reviewed research, we create possibilities that benefit all humanity.

We recognize that Burkina Faso’s legal framework regarding cannabis differs significantly from evolving policies elsewhere. This document doesn’t suggest altering national laws or cultural values. Rather, it offers comprehensive scientific information for educational purposes, acknowledging that knowledge itself has value regardless of immediate application.

The Centre-Est Region, with its agricultural heritage, growing educational infrastructure, and connection to broader West African scientific communities, represents precisely the kind of thoughtful audience that benefits from detailed, accurate, scientifically-grounded information about emerging botanical research.

Whether this knowledge informs academic study, healthcare practice, agricultural innovation, or simply satisfies scientific curiosity, we’re honored to share what we’ve learned through years of research, development, and real-world experience. The future of plant science belongs to those who study it seriously, respect its complexities, and apply its lessons with both wisdom and responsibility.

OilWell Cannabis – 810 Richmond Ave, Houston, TX 77006
Contact: (832) 416-2816 | [email protected]
Website: https://oilwellcbd.com/

This content is for educational purposes only. These statements have not been evaluated by food and drug authorities. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before beginning any new wellness regimen. Always comply with local laws and regulations regarding cannabis and hemp-derived products.

---